Fondaparinux is the first artificially synthesized selective factor Ⅹa inhibitor of pentose. Due to its strong anticoagulant activity and certain safety, it is widely used in clinical practice. Especially for patients with low-molecular-weight heparin intolerance during pregnancy or those with heparin-induced thrombocytopenia, fondaparinux has become the preferred anticoagulant therapeutic drug. Fondaparinux has certain application value in obstetric related diseases such as venous thromboembolism, recurrent miscarriage and fetal growth restriction by inhibiting the activity of factor Ⅹa and not reacting with platelets. This article reviewed the clinical application of fondaparinux in the treatment of obstetrical-related diseases for clinical reference.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |